You are not currently logged in.
Access your personal account or get JSTOR access through your library or other institution:
Immunosuppression in Vivo by a Soluble Form of the CTLA-4 T Cell Activation Molecule
Peter S. Linsley, Philip M. Wallace, Jennifer Johnson, Marylou G. Gibson, JoAnne L. Greene, Jeffrey A. Ledbetter, Cherry Singh and Mark A. Tepper
New Series, Vol. 257, No. 5071 (Aug. 7, 1992), pp. 792-795
Published by: American Association for the Advancement of Science
Stable URL: http://www.jstor.org/stable/2877673
Page Count: 4
Preview not available
In vitro, when the B7 molecule on the surface of antigen-presenting cells binds to the T cell surface molecules CD28 and CTLA-4, a costimulatory signal for T cell activation is generated. CTLA4Ig is a soluble form of the extracellular domain of CTLA-4 and binds B7 with high avidity. CTLA4Ig treatment in vivo suppressed T cell-dependent antibody responses to sheep erythrocytes or keyhole limpet hemocyanin. Large doses of CTLA4Ig suppressed responses to a second immunization. Thus, costimulation by B7 is important for humoral immune responses in vivo, and interference with costimulation may be useful for treatment of antibody-mediated autoimmune disease.
Science © 1992 American Association for the Advancement of Science